Biotricity, Inc. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was USD 2.97 million compared to USD 2.46 million a year ago. Net loss was USD 2.81 million compared to USD 4.52 million a year ago. Basic loss per share from continuing operations was USD 0.339 compared to USD 0.546 a year ago.
For the nine months, sales was USD 8.89 million compared to USD 6.9 million a year ago. Net loss was USD 9.91 million compared to USD 13.99 million a year ago. Basic loss per share from continuing operations was USD 1.191 compared to USD 1.699 a year ago.